Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 6,609 |
|
|||||
| News | - | ||||||
| Day High | 2.79 | Low High |
|||||
| Day Low | 2.65 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eupraxia Pharmaceuticals Inc | EPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 1.48% | 2.74 | 15:57:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.79 | 2.65 | 2.79 | 2.70 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 29 | 6,609 | $ 2.70 | $ 17,819 | - | 2.48 - 3.55 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:57:44 | 201 | $ 2.74 | USD |
Eupraxia Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 100.12M | 27.28M | - | 0 | -28.22M | -1.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eupraxia Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.07 | 3.08 | 2.65 | 2.86 | 19,666 | -0.33 | -10.75% |
| 1 Month | 3.55 | 3.55 | 2.48 | 2.84 | 32,083 | -0.81 | -22.82% |
| 3 Months | 3.55 | 3.55 | 2.48 | 2.84 | 32,083 | -0.81 | -22.82% |
| 6 Months | 3.55 | 3.55 | 2.48 | 2.84 | 32,083 | -0.81 | -22.82% |
| 1 Year | 3.55 | 3.55 | 2.48 | 2.84 | 32,083 | -0.81 | -22.82% |
| 3 Years | 3.55 | 3.55 | 2.48 | 2.84 | 32,083 | -0.81 | -22.82% |
| 5 Years | 3.55 | 3.55 | 2.48 | 2.84 | 32,083 | -0.81 | -22.82% |
Eupraxia Pharmaceuticals Description
| Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. |
